New brain scan study aims to unravel mysteries of speech disorder

NCT ID NCT01818661

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study uses advanced brain scans, including a special PET tracer called AV-1451, to track changes in the brains of 50 people with progressive apraxia of speech (a disorder that affects the ability to coordinate speech movements). Researchers at Mayo Clinic will compare these brain images with changes in speech, language, and thinking over time. The goal is to better understand how the disease progresses, which could improve diagnosis and monitoring in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
AV-1451 (a radioactive tracer used in PET scans to detect tau protein in the brain)
What this could lead to
If successful, this study could help doctors better understand how progressive apraxia of speech affects the brain, potentially leading to earlier diagnosis or better monitoring of the disease.
What could go wrong
This is an observational imaging study, not a treatment trial. It is small (50 participants) and focused on understanding the disease, so it will not directly lead to a new therapy or cure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APRAXIA OF SPEECH are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    RECRUITING

    Rochester, Minnesota, 55905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.